Sinocare Inc. (SHE: 300298), a China-based company, has entered into a partnership agreement with U.S. giant Illumina (NASDAQ: ILMN) to localize the iScan high-end chip scanners. This collaboration aims to harness their technological strengths and resources to enhance the application of genomics in precision health management, with a particular focus on reproductive genetics and chronic disease prevention. Financial terms of the agreement were not disclosed.
The iScan chip scanner is known for its high throughput, sensitivity, and stable output of quality data, making it suitable for various microarray applications, including gene expression analysis, genotype analysis, and methylation analysis.- Flcube.com
